BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang W, Zhang J, Huang T, Zhou Y, Wong CC, Chan RCK, Dong Y, Wu F, Zhang B, Wu WKK, Chan MWY, Cheng ASL, Yu J, Wong N, Lo KW, To KF. NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway. Oncogene 2021;40:1578-94. [PMID: 33452458 DOI: 10.1038/s41388-020-01579-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ji D, Yang Y, Zhou F, Li C. A nine–consensus–prognostic –gene–based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies. Front Genet 2022;13:909175. [DOI: 10.3389/fgene.2022.909175] [Reference Citation Analysis]
2 Sadri F, Hosseini SF, Aghayei A, Fereidouni M, Rezaei Z. The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers. DNA Cell Biol 2022. [PMID: 35914029 DOI: 10.1089/dna.2022.0274] [Reference Citation Analysis]
3 Nakamura H, Sekine H, Kato H, Masai H, Gradin K, Poellinger L. Hypoxia-inducible factor-1α and poly [ADP ribose] polymerase 1 cooperatively regulate Notch3 expression under hypoxia via a non-canonical mechanism. J Biol Chem 2022;:102137. [PMID: 35714766 DOI: 10.1016/j.jbc.2022.102137] [Reference Citation Analysis]
4 Lachej N, Dabkeviciene D, Simiene J, Sabaliauskaite R, Jonusiene V, Brasiunas V, Sasnauskiene A, Vaicekauskaite I, Brasiuniene B, Kanopiene D, Suziedelis K, Didziapetriene J, Pandurangan A. Components of NOTCH Signaling for Uterine Cancer Patients’ Prognosis. Journal of Oncology 2022;2022:1-8. [DOI: 10.1155/2022/8199306] [Reference Citation Analysis]
5 Guo L, Li S, Yan X, Shen L, Xia D, Xiong Y, Dou Y, Mi L, Ren Y, Xiang Y, Ren D, Wang J, Liang T. A comprehensive multi-omics analysis reveals molecular features associated with cancer via RNA cross-talks in the Notch signaling pathway. Computational and Structural Biotechnology Journal 2022;20:3972-85. [DOI: 10.1016/j.csbj.2022.07.036] [Reference Citation Analysis]
6 Lv J, Zhang S, Liu Y, Li C, Guo T, Zhang S, Li Z, Jiao Z, Sun H, Zhang Y, Xu L. NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3. Front Cell Dev Biol 2021;9:688949. [PMID: 34746118 DOI: 10.3389/fcell.2021.688949] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Huang WC, Chi HC, Tung SL, Chen PM, Shih YC, Huang YC, Chu PY. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 2021;10:2524. [PMID: 34685504 DOI: 10.3390/cells10102524] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Ge D, Shao Y, Wang M, Tao H, Mu M, Tao X. RNA-seq-Based Screening in Coal Dust-Treated Cells Identified PHLDB2 as a Novel Lung Cancer-Related Molecular Marker. Biomed Res Int 2021;2021:1978434. [PMID: 34337001 DOI: 10.1155/2021/1978434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Xiu M, Wang Y, Li B, Wang X, Xiao F, Chen S, Zhang L, Zhou B, Hua F. The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies. Front Mol Biosci 2021;8:694141. [PMID: 34195229 DOI: 10.3389/fmolb.2021.694141] [Cited by in F6Publishing: 7] [Reference Citation Analysis]